NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ginkgo Bioworks

Ginkgo Bioworks

Public
Boston, MassachusettsBiotechhttps://www.ginkgobioworks.com

Ginkgo Bioworks is now publicly traded

The data on this page reflects Ginkgo Bioworks's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Sep 16, 2021

Last Round

Series E

Extension

May 28, 2020

Total Funding Raised

$2.42B

Company Overview

Ginkgo Bioworks is a biotechnology company that offers comprehensive cell programming solutions to address challenges in various sectors, including food, agriculture, pharmaceuticals, and industrial chemicals.

Sector

Biotech

AI Layer

Infrastructure

Keywords

cell engineering platformsynthetic biology platform as a serviceautomated synthetic biology foundrybiological R&D servicesproprietary biological codebasecell programming as a servicebiosecurity and pathogen detection servicesenzyme discovery and optimization servicesorganism design and optimization servicesmodular lab automation hardware and softwareADME profiling for drug discoverydownstream value-sharing revenue modelgovernment biosecurity contract services

Ginkgo Bioworks Comparables

Compare Ginkgo Bioworks with similar companies based on industry and business-model similarity.

Ginkgo Bioworks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Ginkgo Bioworks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOSep 16, 2021
Series E ExtensionMay 28, 2020
Series ESep 19, 2019
Series DDec 14, 2017
Series CJun 8, 2016
Series B
Jul 23, 2015

Ginkgo Bioworks Investors

Notable investors and investment history

Ginkgo Bioworks investors
InvestorRounds
Cascade Investment GroupSeries C, Series D
Cascade InvestmentSeries C, Series D, IPO, Series E
Massachusetts Development Finance AgencySeries A
Allen & Company LLCSeries C
Bellco CapitalIPO
ArrowMark PartnersIPO
Collaborative FundSeries A, Seed

Ginkgo Bioworks Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ginkgo Bioworks Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2008
Last FundingMay 28, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.